Ameren Corporation: The underlying trend is to the upside
| Entry price | Target | Stop-loss | Potential |
|---|
|
111 |
116 |
106 |
+4.5% |
|---|
The timing appears opportune to go long in shares of Ameren Corporation as we anticipate another pick-up in the underlying trend.
Strengths● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
● The company returns high margins, thereby supporting business profitability.
● Over the past year, analysts have regularly revised upwards their sales forecast for the company.
● Considering the small differences between the analysts' various estimates, the group's business visibility is good.
● Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
● The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
● Based on current prices, the company has particularly high valuation levels.
© MarketScreener.com -
2026
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
